0.86 -0.01 (-1.15%)

55.44% Fall from 52W High

1.4M XNAS Volume

XNAS 21 Mar, 2025 5:30 PM (EDT)

Board Meeting
The next board meeting for Nektar Therapeutics is on 27 Mar 2025 for the purpose of H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference 2025 See details
Low Financial Strength
16.7 / 100
Expensive Valuation
18.5 / 100
Technically Neutral
42.7 / 100
Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

Nektar Therapeutics Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..

Nektar Therapeutics FAQ

How is Nektar Therapeutics today?
Nektar Therapeutics today is trading in the red, and is down by -1.15% at 0.86.
Nektar Therapeutics is currently trading down -1.15% on an intraday basis. In the past week the stock fell -4.44%. stock has been down -7.53% in the past quarter and fell -5.49% in the past year. You can view this in the overview section.